Match!

When should unexpected weight loss warrant further investigation to exclude cancer

Published on Sep 23, 2019in BMJ27.604
· DOI :10.1136/BMJ.L5271
Brian D Nicholson9
Estimated H-index: 9
(University of Oxford),
Paul Aveyard49
Estimated H-index: 49
(University of Oxford)
+ 1 AuthorsMarites Derit38
Estimated H-index: 38
(University of Oxford)
Abstract
### What you need to know Unexpected weight loss presents a diagnostic challenge in primary care. It is associated with a wide range of benign and serious conditions (box 1).1 Box 1 ### Differential diagnosis for patients with unexpected weight loss1RETURN TO TEXT Weight loss may be missed or misattributed because of several factors (see box 2). Once it is detected, the uncertainty for clinicians is not about whether unexpected weight loss is a symptom of concern, it is about who should be investigated further and who can be spared unnecessary investigation. Specifically, how much weight loss, over how much time, in combination with what other clinical features makes cancer sufficiently likely to warrant urgent investigation? Box 2 ### Challenges in detecting weight loss in primary care #### Physiological factorsRETURN TO TEXT
  • References (47)
  • Citations (1)
📖 Papers frequently viewed together
7 Citations
2010
78% of Scinapse members use related papers. After signing in, all features are FREE.
References47
Newest
#1Brian D NicholsonH-Index: 9
#2Paul AveyardH-Index: 49
Last. Rafael PereraH-Index: 51
view all 8 authors...
© 2019 Nicholson et al. Purpose: To use recorded weight values to internally validate weight status and weight change coding in the primary care Electronic Health Record (EHR). Patients and methods: We included adult patients with weight-related Read codes recorded in the UK’s Clinical Practice Research Datalink EHR between 2000 and 2017. Weight status codes were compared to weight values recorded on the same day and positive predictive values (PPVs) were calculated for commonly used codes. Weig...
1 CitationsSource
#1Bette J. Caan (KP: Kaiser Permanente)H-Index: 74
#2Elizabeth M. Cespedes Feliciano (KP: Kaiser Permanente)H-Index: 15
Last. Wendy Y. Chen (Harvard University)H-Index: 43
view all 11 authors...
Importance Sarcopenia (low muscle mass), poor muscle quality (low muscle radiodensity), and excess adiposity derived from computed tomography (CT) has been related to higher mortality in patients with metastatic breast cancer, but the association with prognosis in patients with nonmetastatic breast cancer is unknown. Objective To evaluate associations of all 3 body composition measures, derived from clinically acquired CT at diagnosis, with overall mortality in nonmetastatic breast cancer. Desig...
39 CitationsSource
#1Alice S ForsterH-Index: 1
#2Cristina RenziH-Index: 11
Last. Georgios LyratzopoulosH-Index: 36
view all 3 authors...
4 CitationsSource
#1Brian D Nicholson (University of Oxford)H-Index: 9
#2Willie Hamilton (University of Exeter)H-Index: 41
Last. Hobbs Fdr. (University of Oxford)H-Index: 7
view all 5 authors...
© British Journal of General Practice. Background: Weight loss is a non-specific cancer symptom for which there are no clinical guidelines about investigation in primary care. Aim: To summarise the available evidence on weight loss as a clinical feature of cancer in patients presenting to primary care. Design and setting: A diagnostic test accuracy review and meta-analysis. Method: Studies reporting 2 × 2 diagnostic accuracy data for weight loss (index test) in adults presenting to primary care ...
5 CitationsSource
#1Minjoung Monica Koo (UCL: University College London)H-Index: 4
#2Willie Hamilton (University of Exeter)H-Index: 41
Last. Georgios Lyratzopoulos (University of Cambridge)H-Index: 36
view all 5 authors...
Abstract Early diagnosis is an important aspect of contemporary cancer prevention and control strategies, as the majority of patients are diagnosed following symptomatic presentation. The nature of presenting symptoms can critically influence the length of the diagnostic intervals from symptom onset to presentation (the patient interval), and from first presentation to specialist referral (the primary care interval). Understanding which symptoms are associated with longer diagnostic intervals to...
10 CitationsSource
#1Audrey Loumaye (UCL: Université catholique de Louvain)H-Index: 9
#2Jean-Paul Thissen (UCL: Université catholique de Louvain)H-Index: 26
Abstract Cachexia is a complex multifactorial syndrome, characterized by loss of skeletal muscle and fat mass, which affects the majority of advanced cancer patients and is associated with poor prognosis. Interestingly, reversing muscle loss in animal models of cancer cachexia leads to prolong survival. Therefore, detecting cachexia and maintaining muscle mass represent a major goal in the care of cancer patients. However, early diagnosis of cancer cachexia is currently limited for several reaso...
14 CitationsSource
#1Bette J. Caan (KP: Kaiser Permanente)H-Index: 74
#2Jeffrey A. Meyerhardt (Harvard University)H-Index: 78
Last. Carla M. Prado (U of A: University of Alberta)H-Index: 34
view all 11 authors...
Background: Body composition may partially explain the U-shaped association between body mass index (BMI) and colorectal cancer survival. Methods: Muscle and adiposity at colorectal cancer diagnosis and survival were examined in a retrospective cohort using Kaplan–Meier curves, multivariable Cox regression, and restricted cubic splines in 3,262 early-stage (I–III) male (50%) and female (50%) patients. Sarcopenia was defined using optimal stratification and sex- and BMI-specific cut points. High ...
55 CitationsSource
#1Fiona M Walter (University of Cambridge)H-Index: 37
#2Katie Mills (University of Cambridge)H-Index: 6
Last. Jon Emery (University of Cambridge)H-Index: 42
view all 11 authors...
Summary Background Pancreatic cancer is the tenth most common cancer in the UK; however, outcomes are poor, in part due to late diagnosis. We aimed to identify symptoms and other clinical and sociodemographic factors associated with pancreatic cancer diagnosis and diagnostic intervals. Methods We did this prospective cohort study at seven hospitals in two regions in England. We recruited participants aged 40 years or older who were referred for suspicion of pancreatic cancer. Data were collected...
16 CitationsSource
#1Marcela EwingH-Index: 2
#2Peter Naredi (University of Gothenburg)H-Index: 28
Last. Jörgen MånssonH-Index: 13
view all 4 authors...
Background Colorectal cancer is the third most common cancer worldwide and second most common in Europe. Despite screening, it is often diagnosed at an unfavourable stage. Aim To identify and quantify features of non-metastatic colorectal cancer in primary care to enable earlier diagnosis by GPs. Design and setting A case-control study was conducted using diagnostic codes from national and regional healthcare databases in Sweden. Method A total of 542 patients diagnosed with non-metastatic color...
8 CitationsSource
#1Sara H. OlsonH-Index: 60
#2Youming XuH-Index: 2
Last. Robert C. KurtzH-Index: 43
view all 9 authors...
ObjectivesWe aimed to determine the severity and co-occurrence of established and potential paraneoplastic conditions in pancreatic cancer (weight loss, new onset diabetes, fatigue, and depression) and their relation to patient characteristics.MethodsUsing information from personal interviews with 5
14 CitationsSource
Cited By1
Newest
#1Brian D Nicholson (University of Oxford)H-Index: 9
#2Willie Hamilton (University of Exeter)H-Index: 41
Last. Paul Aveyard (University of Oxford)H-Index: 49
view all 6 authors...
BACKGROUND: We aimed to understand the time period of cancer diagnosis and the cancer types detected in primary care patients with unexpected weight loss (UWL) to inform cancer guidelines. METHODS: This retrospective matched cohort study used cancer registry linked electronic health records from the UK's Clinical Practice Research Datalink from between 2000 and 2014. Univariable and multivariable time-to-event analyses examined the association between UWL, and all cancers combined, cancer site a...
1 CitationsSource